scispace - formally typeset
Journal ArticleDOI

Curcumin induces stress response, neurite outgrowth and prevent NF-kappaB activation by inhibiting the proteasome function.

Reads0
Chats0
TLDR
It is shown that curcumin disrupts UPS function by directly inhibiting the enzyme activity of the proteasome’s 20S core catalytic component, which causes an increase in half-life of IκB-α that ultimately leads to the down-regulation of NF-κB activation.
Abstract
Curcumin, a natural polyphenolic compound, has long been known as an anti-tumour and anti-inflammatory compound; although, the common mechanism through which it exhibits such properties are remains unclear. Recently, we reported that the curcumin-induced apoptosis is mediated through the impairment of ubiquitin proteasome system (UPS). Here, we show that curcumin disrupts UPS function by directly inhibiting the enzyme activity of the proteasome's 20S core catalytic component. Like other proteasome inhibitors, curcumin exposure induces neurite outgrowth and the stress response, as evident from the induction of various cytosolic and endoplasmic reticulum chaperones as well as induction of transcription factor CHOP/GADD153. The direct inhibition of proteasome activity also causes an increase in half-life of IkappaB-alpha that ultimately leads to the down-regulation of NF-kappaB activation. These results suggest that curcumin-induced proteasomal malfunction might be linked with both anti-proliferative and anti-inflammatory activities.

read more

Citations
More filters
Journal ArticleDOI

Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing.

TL;DR: A review of existing data on the anticancer activities of curcumin, and possible explanations for and mechanisms of its cancer-preventive action is presented in this paper, where the authors also provide insights into the molecular mechanism and targets through which curcurumin modulates cell cycle, apoptotic signals, anti-apoptotic proteins, miRNAs, Wnt/beta-catenin signaling, protein kinases, nuclear factor-κB, proteasome activation, epigenetic regulation including DNA methylation and histone modification.
Journal ArticleDOI

Nuclear factor-kappa β as a therapeutic target for Alzheimer's disease.

TL;DR: Since any impairment in the pathways associated with NF‐κβ signaling causes altered neuronal dynamics, neurotherapeutics using compounds including, antioxidants, bioflavonoids, and non‐steroidal anti‐inflammatory drugs against such abnormalities offer possibilities to rectify aberrant excitatory neuronal activity in AD.
Journal ArticleDOI

Natural polyphenols as proteasome modulators and their role as anti-cancer compounds

TL;DR: Proteasome inhibition is a promising approach to anticancer therapy and such natural antioxidant effectors can be considered as potential relevant adjuvants and pharmacological models in the study of new drugs.
Journal ArticleDOI

Molecular mechanism of curcumin action in signaling pathways: Review of the latest research

TL;DR: Curcumin is capable of crossing the blood-brain barrier, and thus it may protect the neurons from oxidative stress and inflammation, and it is possible to use it in the protection of liver and spleen against oxidative and inflammatory injury.
Journal ArticleDOI

Dual roles of NF-κB in cell survival and implications of NF-κB inhibitors in neuroprotective therapy

TL;DR: The genes regulated by NF-κB that are involved in cell death and survival are summarized to elucidate why NF-σB promotes cell survival in some conditions while facilitating cell death in other conditions and to speculate if NF- ΚB is a potential target for neuroprotective therapy.
References
More filters
Journal ArticleDOI

The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction

TL;DR: It is clear now that degradation of cellular proteins is a highly complex, temporally controlled, and tightly regulated process that plays major roles in a variety of basic pathways during cell life and death as well as in health and disease.
Journal Article

Anticancer potential of curcumin: preclinical and clinical studies.

TL;DR: Evidence has also been presented to suggest that curcumin can suppress tumor initiation, promotion and metastasis, and Pharmacologically,Curcumin has been found to be safe.
Journal ArticleDOI

Pharmacology of Curcuma longa

TL;DR: It appears that when given orally, curcumin is far less active than after i.p. administration, and systemic effects seem to be questionable after oral application except that they occur at very low concentrations ofCurcumin, which does not exclude a local action in the gastrointestinal tract.
Journal ArticleDOI

Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)

TL;DR: It is demonstrated that curcumin (diferuloylmethane), a known anti-inflammatory and anticarcinogenic agent, is a potent inhibitor of NF-κB activation.
Journal ArticleDOI

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

TL;DR: The molecular sequelae of PS-341 treatment in MM cells are characterized and the rationale for future clinical trials of this promising agent, in combination with conventional and novel therapies, to improve patient outcome in MM is explained.
Related Papers (5)